Most wellness brands waste months on launches because their marketing team doesn't understand FDA constraints. Get a growth leader who's navigated regulatory requirements before — and actually moved the revenue needle.
FDA compliance requirements derail launch timelines when marketing doesn't understand regulatory constraints
Your product works, but marketing can't make the claims that drive conversions. Without compliance expertise, every campaign becomes a legal review nightmare that kills momentum. This directly impacts patient/customer acquisition cost, making it harder to justify marketing spend to leadership. FDA and FTC compliance requirements add 3-6 months to launch timelines when marketing teams lack regulatory experience
Customer acquisition costs spike 40% year-over-year without clinical data to differentiate products
Wellness consumers are skeptical after years of unsubstantiated claims. Without clinical evidence integration, you're competing on lifestyle positioning — which means higher CACs and lower trust. This directly impacts clinical outcome metrics, making it harder to justify marketing spend to leadership. Clinical evidence requirements create content bottlenecks — you cannot make claims without substantiation
Consumer trust issues plague digital health brands after privacy scandals and unsubstantiated claims
Health consumers are more cautious than ever. Generic wellness messaging doesn't build the trust required for high-consideration health purchases, especially in digital-first brands. This directly impacts regulatory approval timeline, making it harder to justify marketing spend to leadership. Consumer trust erosion after years of unsubstantiated wellness claims makes acquisition harder and more expensive
We don't just do health marketing. We build growth systems that work within regulatory reality. Your wellness company needs someone who's launched health products before — not a generalist learning compliance on your timeline. We create FDA-compliant go-to-market strategies that actually accelerate launches while integrating clinical evidence to build consumer trust. This isn't about more creative — it's about smarter positioning that turns regulatory constraints into competitive advantages. We start with your compliance framework, map your clinical data to conversion drivers, and build trust-building systems that compound customer confidence over time.
Our approach starts with a thorough assessment of your current growth infrastructure. We review what is working, what is not, and where the highest-impact opportunities are. This diagnostic phase ensures we are solving the right problems before committing resources to execution.
What makes our approach different: embedded leadership model — not external consulting, operator mentality — we own the number, not just the strategy, 90-day sprint approach with clear phase gates. We operate as an extension of your team, not as outside advisors delivering slide decks. The fractional model means you get senior expertise without the overhead of a full-time hire, and the 90-day sprint structure ensures you see measurable progress at every phase.
We build measurement into every engagement from day one. Before we change anything, we establish baseline metrics so progress is tracked against real numbers. Monthly reporting shows what is working, what needs adjustment, and where to invest next. No vanity metrics — only indicators that connect to revenue.
Most wellness brands waste months on launches because their marketing team doesn't understand FDA constraints.
Our methodology starts with a 90-day sprint designed to create immediate impact while building long-term systems. In the first 30 days, we embed with your leadership team to audit existing marketing infrastructure, review performance data, identify quick wins, and understand the competitive landscape specific to your vertical. We interview key stakeholders, review your analytics stack, and map the customer journey from first touch to closed deal.
Days 30-60 focus on strategy development and early execution. We build a prioritized growth roadmap, restructure team roles where needed, and start implementing the highest-impact changes. This phase includes establishing measurement frameworks so we can track progress against real metrics, not vanity numbers.
Days 60-90 shift to full execution mode. Systems are running, the team is aligned, and we're optimizing based on real data. By the end of the sprint, you have a functioning growth engine with clear ownership and accountability — something that works whether we stay on or not.
In the first 30 days, we conduct a full marketing and growth audit. This includes reviewing your analytics stack, interviewing key stakeholders, mapping the customer journey, and identifying the three to five highest-impact opportunities. We establish baseline metrics so we can measure progress against real targets.
During days 30-60, we move into strategy development and early execution. We build a prioritized growth roadmap, begin restructuring team roles where needed, and start implementing quick wins identified in the audit phase. Weekly check-ins keep the team aligned and the leadership team informed.
Days 60-90 are full execution mode. Systems are running, the team knows their roles, and we're optimizing based on real performance data. We provide monthly strategy presentations to the leadership team covering what's working, what's not, and what we're changing.
Most engagements run 3-6 months initially. We work 15-25 hours per week embedded with your team — attending leadership meetings, managing agency relationships, and making resource allocation decisions. The goal is to build systems that outlast the engagement.
If your health & wellness company needs fractional cxo leadership, we should talk.
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Our health & wellness fractional CXO engagements run $18K-$28K monthly depending on regulatory complexity and clinical evidence requirements. Much less than hiring a CMO who needs to learn health compliance on your dime.
We're not regulatory consultants, but we build marketing strategies that work within FDA/FTC constraints. We've launched dozens of health products — we know what claims you can make and which ones trigger review delays.
We position clinical data as proof points, not promises. The key is showing evidence without making therapeutic claims — building trust through transparency rather than overstated benefits.
Health consumers need more trust signals, longer education cycles, and evidence-based positioning. Plus regulatory constraints that make standard growth tactics impossible. You need someone who's navigated this before.
Yes, though the strategies are completely different. B2B healthcare requires clinical evidence and regulatory compliance. DTC wellness focuses on lifestyle integration and consumer trust building. We adapt our approach to your market.
Tuesday, March 24, 2026
Frank Growth – Episode 212 – Getting Your Mind Right for Growth with Dan Kessler
Tuesday, March 31, 2026
Frank Growth – Episode 213 – Buy a SaaS, Skip the Startup with Doug Breaker
Tuesday, March 17, 2026
Frank Growth – Episode 211 – Kill the CMO Role with Elia Wallen
Tuesday, March 10, 2026
Frank Growth – Episode 210 – The Art & Science of Product Marketing with Seif Salama
Ready to unlock your growth?
Book Free Call